deltatrials
Completed NA NCT00001115

The Effect of Acyclovir Treatment of the Herpes Simplex Virus (HSV) Infection on HIV Levels in the Blood

A Pilot Study to Determine the Effect of Acyclovir Treatment for Herpes Simplex Virus (HSV) Infection on Peripheral Blood HIV Viral Load.

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Conditions HIV Infections Herpes Simplex
Interventions Acyclovir
Updated 5 times since 2017 Last updated: Oct 27, 2016 Primary completion: Jun 30, 2005 Completion: Jun 30, 2005

Listed as NCT00001115, this NA trial focuses on HIV Infections and Herpes Simplex and remains completed. Sponsored by National Institute of Allergy and Infectious Diseases (NIAID), it has been updated 5 times since 2026, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2021 — Jul 2024 [monthly]

    Completed NA

  4. Jun 2018 — Jan 2021 [monthly]

    Completed NA

  5. Jan 2017 — Jun 2018 [monthly]

    Completed NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Institute of Allergy and Infectious Diseases (NIAID)
Data source: National Institute of Allergy and Infectious Diseases (NIAID)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Baltimore, United States, Brooklyn, United States, Chicago, United States, Fort Lauderdale, United States, Miami, United States, New Haven, United States, New York, United States, Palo Alto, United States, Philadelphia, United States, Portland, United States and 3 more location s